Top Markets
#1 MowCat MowCat +369.14%
#2 龙虾 (Lobster) 龙虾 (Lobster) +67.78%
#3 SODAX SODAX +51.82%
#4 Cortex Cortex +33.34%
#5 DexNet DexNet +23.19%
#6 OpenEden OpenEden +21.97%
#7 BNB Attestation Service BNB Attestation Service +20.72%
#8 Magma Finance Magma Finance +16.49%
#9 wojak wojak +16.15%
#10 Akedo Akedo +15.73%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
Chinook Therapeutics, Inc. Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc.

KDNY
株式のランク #7139
Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical... Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical development phase, is dedicated to the identification, progression, and market introduction of precise medical treatments for kidney-related conditions. The company's primary therapeutic candidate, atrasentan, is an endothelin receptor antagonist currently in Phase III clinical trials. This drug aims to treat IgA nephropathy and various other glomerular diseases characterized by proteinuria. Beyond its lead program, Chinook's investigational pipeline includes BION-1301, an anti-APRIL monoclonal antibody, which is presently being evaluated in a Phase I/II study for IgA nephropathy. Another promising candidate is CHK-336, an oral small molecule designed to inhibit LDHA, intended for patients with primary hyperoxaluria. The firm also maintains active research initiatives exploring solutions for other uncommon and severe chronic kidney ailments. Chinook Therapeutics, Inc. is based in Seattle, Washington.
株価
$40.39
最終同期: 2023-08-18
時価総額
$1.70B
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Chinook Therapeutics, Inc. (KDNY)

カテゴリー

Healthcare
Chinook Therapeutics, Inc.（KDNY）の配当利回りの履歴
Chinook Therapeutics, Inc.（銘柄コード: KDNY）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Chinook Therapeutics, Inc.（KDNY）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH